Increased levels of MMP-2 and 9 were observed in CSF of high-grade glioma patients [51], and a larger study confirmed increased plasma levels of MMP-9 and TIMP-1 in patients with both grade II and IV glioma compared to healthy controls [95]. This evidence concerns the gene MMP2 and glioma.